Symposia: Acute Lymphoblastic Leukemias: Biomarkers, Molecular Markers, and Minimal Residual Disease in Diagnosis and Prognosis
Program: Oral and Poster Abstracts
Type: Poster
Hematology Disease Topics & Pathways:
Research, Artificial intelligence (AI), Lymphoid Leukemias, ALL, Fundamental Science, Adult, Bispecific Antibody Therapy, Lymphomas, Translational Research, CHIP, Assays, Genomics, Bioinformatics, Clinical Research, Hematopoiesis, Pediatric, Education, Diseases, Immune mechanism, Treatment Considerations, Biological therapies, Immunology, Immunotherapy, Lymphoid Malignancies, Computational biology, Biological Processes, Emerging technologies, Technology and Procedures, Molecular biology, Study Population, Profiling, Human, Pathogenesis, Imaging, Measurable Residual Disease , Machine learning, Molecular testing, Omics technologies, Pathology
Type: Poster
Hematology Disease Topics & Pathways:
Research, Artificial intelligence (AI), Lymphoid Leukemias, ALL, Fundamental Science, Adult, Bispecific Antibody Therapy, Lymphomas, Translational Research, CHIP, Assays, Genomics, Bioinformatics, Clinical Research, Hematopoiesis, Pediatric, Education, Diseases, Immune mechanism, Treatment Considerations, Biological therapies, Immunology, Immunotherapy, Lymphoid Malignancies, Computational biology, Biological Processes, Emerging technologies, Technology and Procedures, Molecular biology, Study Population, Profiling, Human, Pathogenesis, Imaging, Measurable Residual Disease , Machine learning, Molecular testing, Omics technologies, Pathology
Monday, December 9, 2024: 6:00 PM-8:00 PM
Halls G-H
(San Diego Convention Center)
See more of: Oral and Poster Abstracts
*signifies non-member of ASH